Show simple item record

dc.contributor.authorPolak, L
dc.contributor.authorGreen, J
dc.date.accessioned2020-05-07T13:37:00Z
dc.date.issued2020-01-10
dc.description.abstractTo understand decision-making in the context of longterm preventive medication, we explore the way “deciding” articulates with household medication practices and other everyday routines. Taking statins as a case study, we use qualitative data from interviews with 34 participants in the UK who had all been offered statins; 19 were currently taking them. Although all participants reference similar information about statins, the way they assemble and use their knowledge varies: there is a marked asymmetry between participants taking statins and those not taking them. Deliberation is a prominent feature of accounts of deciding not to take statins, but seldom visible within accounts of those taking them. Statin-takers emphasise that they have “no choice” about taking them, while non-takers stress the need to “think about it”; statin-takers’ accounts prioritise biomedical tests over experiential knowledge, whereas non-takers sometimes prioritise experiential knowledge. All participants reference similar theoretical and experiential knowledge about side-effects, but whereas non-takers often use this knowledge to explain their decision to decline statins, those taking statins downplay both their own experiences and the likelihood that these are due to statins. To account for these asymmetries, we propose a model of decision-making in which deciding upon a course of action entails constructing a narrative presentation of medication use that frames it as “the right thing to do”. This model helps us examine the two-way interactions between decision-making and the material practices through which regular medication gets taken, interactions often elided from accounts both of decision-making and of medication practice. In the context of longterm medication, the boundaries between “deciding” and “doing” are blurred; decision-making is situated within a web of collaborative, discursively-informed practices.en_GB
dc.identifier.citationVol. 247, article 112797en_GB
dc.identifier.doi10.1016/j.socscimed.2020.112797
dc.identifier.urihttp://hdl.handle.net/10871/120971
dc.language.isoenen_GB
dc.publisherElsevieren_GB
dc.rights.embargoreasonUnder embargo until 10 january 2021 in compliance with publisher policyen_GB
dc.rights© 2020. This version is made available under the CC-BY-NC-ND 4.0 license: https://creativecommons.org/licenses/by-nc-nd/4.0/  en_GB
dc.subjectUKen_GB
dc.subjectDecision-makingen_GB
dc.subjectMedication practicesen_GB
dc.subjectKnowledge constructionen_GB
dc.subjectQualitativeen_GB
dc.subjectStatinsen_GB
dc.titleRethinking decision-making in the context of preventive medication: How taking statins becomes “the right thing to do”en_GB
dc.typeArticleen_GB
dc.date.available2020-05-07T13:37:00Z
dc.identifier.issn0277-9536
dc.descriptionThis is the author accepted manuscript. The final version is available from Elsevier via the DOI in this recorden_GB
dc.identifier.journalSocial Science and Medicineen_GB
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/  en_GB
dcterms.dateAccepted2020-01-09
rioxxterms.versionAMen_GB
rioxxterms.licenseref.startdate2020-01-10
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2020-05-07T13:34:53Z
refterms.versionFCDAM
refterms.dateFOA2021-01-10T00:00:00Z
refterms.panelCen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2020. This version is made available under the CC-BY-NC-ND 4.0 license: https://creativecommons.org/licenses/by-nc-nd/4.0/  
Except where otherwise noted, this item's licence is described as © 2020. This version is made available under the CC-BY-NC-ND 4.0 license: https://creativecommons.org/licenses/by-nc-nd/4.0/